As far as I know there is no new news. The trial isn't listed on clinicaltrials.gov.Anything you guys know? When they will give more details?
There is a recent company presentation with information on pages 13 and 14 though there isn't really any new information:
http://phx.corporate-ir.net/Externa...9NjM2MDMyfENoaWxkSUQ9MzQwMjM3fFR5cGU9MQ==&t=1
I don't think Otonomy has said anything explicitly about chronic vs acute, but the assumption is that it will be for acute. Auris belies that as they point out in a SEC filing last year that OTO-311 is likely to be a competitor to AM-101.
http://ir.aurismedical.com/phoenix....ERVNDPVNFQ1RJT05fUEFHRSZleHA9JnN1YnNpZD01Nw==
The filing warns that OTO-104 is a likely competitor for AM-111. They also state/imply that they have patents that Otonomy may be infringing.